Lamotrigine
Lamictal, Lamictal Cd, Lamictal Odt (lamotrigine) is a small molecule pharmaceutical. Lamotrigine was first approved as Lamictal on 1994-12-27. It is used to treat bipolar disorder, epilepsy, lennox gastaut syndrome, mood disorders, and partial epilepsies amongst others in the USA. It is known to target sodium channel protein type 2 subunit alpha. Lamictal's patents are valid until 2029-01-04 (FDA).
| Trade Name | Lamictal, Lamictal Cd, Lamictal Odt |
|---|---|
| Common Name | Lamotrigine |
| Indication | bipolar disorder, epilepsy, lennox gastaut syndrome, mood disorders, partial epilepsies, seizures |
| Drug Class | Sodium channel blockers, signal transduction modulators |
